Legal & General Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.2M Sell
1,364,639
-2,239
-0.2% -$41.3K 0.01% 775
2025
Q1
$23.9M Buy
1,366,878
+22,542
+2% +$394K 0.01% 760
2024
Q4
$23.3M Sell
1,344,336
-95,487
-7% -$1.65M 0.01% 787
2024
Q3
$26.8M Sell
1,439,823
-139,630
-9% -$2.6M 0.01% 751
2024
Q2
$24.3M Sell
1,579,453
-280,115
-15% -$4.31M 0.01% 773
2024
Q1
$27.5M Sell
1,859,568
-26,953
-1% -$398K 0.01% 744
2023
Q4
$26.9M Buy
1,886,521
+97,762
+5% +$1.4M 0.01% 758
2023
Q3
$24.9M Sell
1,788,759
-12,909
-0.7% -$180K 0.01% 750
2023
Q2
$21.2M Buy
1,801,668
+45,806
+3% +$539K 0.01% 829
2023
Q1
$20.2M Buy
1,755,862
+132,100
+8% +$1.52M 0.01% 812
2022
Q4
$20.2M Buy
1,623,762
+54,470
+3% +$677K 0.01% 818
2022
Q3
$20.6M Sell
1,569,292
-67,248
-4% -$882K 0.01% 787
2022
Q2
$22.9M Buy
1,636,540
+53,264
+3% +$744K 0.01% 793
2022
Q1
$23.6M Sell
1,583,276
-47,995
-3% -$715K 0.01% 843
2021
Q4
$22.1M Buy
1,631,271
+82,638
+5% +$1.12M 0.01% 879
2021
Q3
$22.8M Buy
1,548,633
+54,048
+4% +$796K 0.01% 852
2021
Q2
$27.2M Sell
1,494,585
-33,260
-2% -$605K 0.01% 817
2021
Q1
$26.5M Buy
1,527,845
+30,987
+2% +$538K 0.01% 809
2020
Q4
$26M Buy
1,496,858
+50,423
+3% +$876K 0.01% 772
2020
Q3
$19.9M Buy
1,446,435
+113,100
+8% +$1.56M 0.01% 792
2020
Q2
$19.2M Buy
1,333,335
+109,693
+9% +$1.58M 0.01% 801
2020
Q1
$13.4M Buy
1,223,642
+187,019
+18% +$2.04M 0.01% 829
2019
Q4
$22.1M Buy
1,036,623
+73,239
+8% +$1.56M 0.01% 788
2019
Q3
$22.1M Buy
963,384
+110,715
+13% +$2.54M 0.01% 765
2019
Q2
$16.8M Buy
852,669
+147,908
+21% +$2.91M 0.01% 827
2019
Q1
$13.7M Buy
704,761
+23,675
+3% +$461K 0.01% 818
2018
Q4
$11.2M Sell
681,086
-551
-0.1% -$9.08K 0.01% 806
2018
Q3
$15.8M Sell
681,637
-5,225
-0.8% -$121K 0.01% 767
2018
Q2
$14.9M Sell
686,862
-9,282
-1% -$202K 0.01% 781
2018
Q1
$12.3M Buy
696,144
+100,630
+17% +$1.78M 0.01% 785
2017
Q4
$11.2M Buy
595,514
+20,093
+3% +$377K 0.01% 780
2017
Q3
$12.6M Buy
575,421
+305,560
+113% +$6.7M 0.01% 740
2017
Q2
$6.5M Buy
269,861
+18,675
+7% +$450K 0.01% 859
2017
Q1
$7.01M Buy
251,186
+5,888
+2% +$164K 0.01% 823
2016
Q4
$5.99M Buy
245,298
+32,582
+15% +$795K 0.01% 837
2016
Q3
$5.36M Buy
212,716
+46,286
+28% +$1.17M 0.01% 769
2016
Q2
$3.43M Buy
166,430
+36,160
+28% +$745K ﹤0.01% 828
2016
Q1
$2.61M Buy
130,270
+10,501
+9% +$211K ﹤0.01% 846
2015
Q4
$2.43M Buy
119,769
+165
+0.1% +$3.34K ﹤0.01% 897
2015
Q3
$2.77M Buy
119,604
+15,885
+15% +$368K ﹤0.01% 843
2015
Q2
$2.67M Buy
103,719
+5,128
+5% +$132K ﹤0.01% 860
2015
Q1
$3.27M Buy
98,591
+6,456
+7% +$214K ﹤0.01% 799
2014
Q4
$2.8M Buy
92,135
+9,506
+12% +$289K ﹤0.01% 820
2014
Q3
$2.01M Buy
82,629
+13,841
+20% +$337K ﹤0.01% 857
2014
Q2
$1.98M Buy
68,788
+10,340
+18% +$297K ﹤0.01% 861
2014
Q1
$1.63M Sell
58,448
-4,200
-7% -$117K ﹤0.01% 870
2013
Q4
$1.64M Hold
62,648
﹤0.01% 859
2013
Q3
$1.44M Hold
62,648
﹤0.01% 862
2013
Q2
$1.64M Buy
+62,648
New +$1.64M ﹤0.01% 804